High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes

QR Code

High-Normal Serum Thyrotropin Levels Increased the Risk of Non-Alcoholic Fatty Liver Disease in Euthyroid Subjects with Type 2 Diabetes

Ying Tan,1,* Xixiang Tang,1,2,* Panwei Mu,1 Yi Yang,1 Mei Li,1,2 Yuanpeng Nie,1 Haicheng Li,1 Yanhua Zhu,1 Yanming Chen1 1Department of Endocrinology & Metabolism, The Third Affiliated Hospital of Sun Yat-sen University, Guangdong Provincial Key Laboratory of Diabetology, Guangzhou, People&a...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Tan Y, Tang X, Mu P, Yang Y, Li M, Nie Y, Li H, Zhu Y, Chen Y
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	non-alcoholic fatty liver disease，type 2 diabetes thyroid hormone Specialties of internal medicine RC581-951
Accès en ligne:	https://doaj.org/article/cee5608a5c80428b8c44f22b05ea56f0
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Cytoprotective and suicidal signaling in oxidative stress
par: Videla,Luis A
Publié: (2010)

Elevated TPOAb is a Strong Predictor of Autoimmune Development in Patients of Type 2 Diabetes Mellitus and Non-Alcoholic Fatty Liver Disease: A Case–Control Study
par: Wang C, et autres
Publié: (2020)

Diagnostic significance of clinical and laboratory indices in predicting non-alcoholic fatty liver disease during screening studies
par: Aleksandr E. Nosov, et autres
Publié: (2021)

The Association Between Serum Thyrotropin Within the Reference Range and Metabolic Syndrome in a Community-Based Chinese Population
par: Li M, et autres
Publié: (2020)

Non-Alcoholic Fatty Liver Disease and Hypothyroidism: Review of Clinical and Experimental Studies
par: Tetiana Ranhulova
Publié: (2021)

Causes of death in patients with Non-alcoholic Fatty Liver Disease (NAFLD), alcoholic liver disease and chronic viral Hepatitis B and C
par: Pegah Golabi, et autres
Publié: (2022)

Thyroid Hormone Changes in Euthyroid Patients with Diabetes
par: Qin K, et autres
Publié: (2020)

The association between serum TSH concentration whithin the normal range and nutritional status in euthyroid pregnant women at the first trimester of gestation
par: Farahnaz Mardanian, et autres
Publié: (2021)

Association between serum TSH levels and metabolic components in euthyroid subjects: a nationwide population-based study
par: Ren R, et autres
Publié: (2019)

Non-Alcoholic Fatty Liver Disease as a Risk for Colorectal Cancer Development and the Role of Screening Colonoscopy in Clinical Practice
par: Cosmas Rinaldi Adithya Lesmana, et autres
Publié: (2019)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
par: Satoru Hagiwara, et autres
Publié: (2021)

Diagnostics and treatment of non-alcoholic fatty liver disease with concomitant asthenic syndrome
par: Aleksandr I. Pavlov, et autres
Publié: (2021)

Sensitivity to Thyroid Hormone Indices Are Closely Associated With NAFLD
par: Shuiqing Lai, et autres
Publié: (2021)

The Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
par: Siyu Yu, et autres
Publié: (2021)

A Non-Invasive Prediction Model for Non-Alcoholic Fatty Liver Disease in Adults with Type 2 Diabetes Based on the Population of Northern Urumqi, China
par: Xue M, et autres
Publié: (2021)

Current concepts of the pathogenesis of non-alcoholic fatty liver disease
par: Evgenia Pavlovna Kosobyan, et autres
Publié: (2010)

Adiponutrin and Adiponectin Gene Variants in Indonesian Patients with Non-Alcoholic Fatty Liver Disease: a Preliminary Study
par: Rayvita AN Meagratia, et autres
Publié: (2021)

Activation and Functional Priming of Blood Neutrophils in Non-Alcoholic Fatty Liver Disease Increases in Non-Alcoholic Steatohepatitis
par: Lauszus JS, et autres
Publié: (2021)

Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) Registry
par: Alswat K, et autres
Publié: (2021)

Body Mass Index and Indicators of Lipid Exchange in Liver Steatosis of Alcoholic and Nonalcoholic Genesis in Residents of Rural Area: Similarities and Differences
par: N. V. Mikhaylova, et autres
Publié: (2019)

Verapamil induces autophagy to improve liver regeneration in non-alcoholic fatty liver mice
par: Jian-Lin Lai, et autres
Publié: (2021)

Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
par: Daniela Maria Tanase, et autres
Publié: (2021)

Total polyunsaturated fatty acid intake and the risk of non-alcoholic fatty liver disease in Chinese Han adults: a secondary analysis based on a case–control study
par: Yong Xie, et autres
Publié: (2021)

Obesity and nonalcoholic fatty liver disease: current perspectives
par: Sarwar R, et autres
Publié: (2018)

PRESENCE OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS OF UNCONTROLLED AND CONTROLLED TYPE 2 DIABETES MELLITUS
par: Aqeela Rashid, et autres
Publié: (2019)

Associations of Thyroid Hormone Levels and Macrovascular Complications in Euthyroid Type 2 Diabetic Patients
par: Hu Y, et autres
Publié: (2021)

Non-Alcoholic Fatty Liver Disease (NAFLD) and Potential Links to Depression, Anxiety, and Chronic Stress
par: Sue Shea, et autres
Publié: (2021)

Effect of Saxagliptin, a Dipeptidyl Peptidase 4 Inhibitor, on Non-Alcoholic Fatty Liver Disease
par: Chen L, et autres
Publié: (2020)

Astragaloside IV Alleviates Liver Inflammation, Oxidative Stress and Apoptosis to Protect Against Experimental Non-Alcoholic Fatty Liver Disease
par: Liang XY, et autres
Publié: (2021)

The Role of Notch Signaling Pathway in Non-Alcoholic Fatty Liver Disease
par: Hao Xu, et autres
Publié: (2021)

Ethnic differences and heterogeneity in genetic and metabolic makeup contributing to nonalcoholic fatty liver disease
par: Szanto KB, et autres
Publié: (2019)

Relationship between nonalcoholic fatty liver disease and bone mineral density in adolescents with obesity: a meta-analysis
par: Sun Y, et autres
Publié: (2019)

Impact of Genetic Polymorphism on Response to Therapy in Non-Alcoholic Fatty Liver Disease
par: José Ignacio Martínez-Montoro, et autres
Publié: (2021)

Inadequate identification of fatty liver disease, obesity, and metabolic syndrome by family physicians
par: Mahamid M, et autres
Publié: (2018)

Non-invasive Diagnostics of Liver Fibrosis
par: Mihaylov R., et autres
Publié: (2017)

Glucocorticoid-Induced Fatty Liver Disease
par: Rahimi L, et autres
Publié: (2020)

Effects of naringenin supplementation in overweight/obese patients with non-alcoholic fatty liver disease: study protocol for a randomized double-blind clinical trial
par: Fatemeh Naeini, et autres
Publié: (2021)

Fatty Acids Inhibit LAMP2-Mediated Autophagy Flux via Activating ER Stress Pathway in Alcohol-Related Liver DiseaseSummary
par: Wei Guo, et autres
Publié: (2021)

Association of insulin resistance and non-alcoholic fatty liver disease
par: Ekaterina E. Mishina, et autres
Publié: (2021)

Changes in Fetuin-B and RBP4 During A Course of High-Intensity Interval Training in Women with Nonalcoholic Fatty Liver
par: B Gorbanian, et autres
Publié: (2021)